Idaho Technology, Inc., has announced it has changed the corporate name to BioFire Diagnostics, Inc. The new name reflects the growing breadth of the company’s service in molecular diagnostics. The company has also relaunched its website to reveal its new branding.
“We are excited to announce our new name to our customers and industry members,” says Kirk Ririe, Chief Executive Officer of BioFire Diagnostics. “The new name highlights our expanded presence in the clinical diagnostics market. We have established strong momentum in the diagnostics marketplace, and the new branding under BioFire Diagnostics better reflects the markets we serve.”
BioFire Diagnostics will continue to focus on leveraging its FilmArray pathogen detection system to develop multiplex diagnostic tests for various clinical applications. The FilmArray Respiratory Panel (RP) is FDA-cleared for 20 viral and bacterial respiratory pathogens. BioFire now provides the only FDA-cleared clinical diagnostic test for eight of the 20 organisms in its panel. In addition to the FilmArray RP, BioFire is developing similar FilmArray panels for pathogen identification in blood culture, gastrointestinal infections, meningitis, and more. BioFire also is continuing to develop biosurveillance products such as its PCR-based biodetection system RAZOR EX and the FilmArray BioSurveillance System. View the company’s relaunched website.
